These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24975838)

  • 1. Zoledronic acid affects the cytotoxic effects of Chlamydia pneumoniae and the modulation of cytokine production in human osteosarcoma cells.
    Rizzo A; Misso G; Bevilacqua N; Donnarumma G; Lombardi A; Galdiero M; Caraglia M
    Int Immunopharmacol; 2014 Sep; 22(1):66-72. PubMed ID: 24975838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone-related growth factors and zoledronic acid regulate the PTHrP/PTH.1 receptor bioregulation systems in MG-63 human osteosarcoma cells.
    Tenta R; Sourla A; Lembessis P; Koutsilieris M
    Anticancer Res; 2006; 26(1A):283-91. PubMed ID: 16475708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent modulation of Chlamydia pneumoniae infection cycle in human monocytic and endothelial cells by iron, tryptophan availability and interferon gamma.
    Bellmann-Weiler R; Martinz V; Kurz K; Engl S; Feistritzer C; Fuchs D; Rupp J; Paldanius M; Weiss G
    Immunobiology; 2010; 215(9-10):842-8. PubMed ID: 20646782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of proinflammatory cytokines in human osteoblastic cells by Chlamydia pneumoniae.
    Rizzo A; Di Domenico M; Carratelli CR; Mazzola N; Paolillo R
    Cytokine; 2011 Nov; 56(2):450-7. PubMed ID: 21803599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition and sensitization to cisplatin by zoledronic acid in osteosarcoma cells.
    Benassi MS; Chiechi A; Ponticelli F; Pazzaglia L; Gamberi G; Zanella L; Manara MC; Perego P; Ferrari S; Picci P
    Cancer Lett; 2007 Jun; 250(2):194-205. PubMed ID: 17113707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer effects of zoledronic acid against human osteosarcoma cells.
    Kubista B; Trieb K; Sevelda F; Toma C; Arrich F; Heffeter P; Elbling L; Sutterlüty H; Scotlandi K; Kotz R; Micksche M; Berger W
    J Orthop Res; 2006 Jun; 24(6):1145-52. PubMed ID: 16602111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activity of zoledronic Acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation.
    Peng H; Sohara Y; Moats RA; Nelson MD; Groshen SG; Ye W; Reynolds CP; DeClerck YA
    Cancer Res; 2007 Oct; 67(19):9346-55. PubMed ID: 17909043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effects of bisphosphonate and radiation on osteosarcoma cells.
    Ryu K; Murata H; Koto K; Horie N; Matsui T; Nishigaki Y; Sakabe T; Takeshita H; Itoi M; Kimura S; Ashihara E; Maekawa T; Fushiki S; Kubo T
    Anticancer Res; 2010 Jul; 30(7):2713-20. PubMed ID: 20683003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking HSP90 Addiction Inhibits Tumor Cell Proliferation, Metastasis Development, and Synergistically Acts with Zoledronic Acid to Delay Osteosarcoma Progression.
    Ory B; Baud'huin M; Verrecchia F; Royer BB; Quillard T; Amiaud J; Battaglia S; Heymann D; Redini F; Lamoureux F
    Clin Cancer Res; 2016 May; 22(10):2520-33. PubMed ID: 26712686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel.
    Jagdev SP; Coleman RE; Shipman CM; Rostami-H A; Croucher PI
    Br J Cancer; 2001 Apr; 84(8):1126-34. PubMed ID: 11308265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vitro anti-tumour activity of zoledronic acid and docetaxel at clinically achievable concentrations in prostate cancer.
    Morgan C; Lewis PD; Jones RM; Bertelli G; Thomas GA; Leonard RC
    Acta Oncol; 2007; 46(5):669-77. PubMed ID: 17562444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteosarcoma cell line growth inhibition by zoledronate-stimulated effector cells.
    Muraro M; Mereuta OM; Carraro F; Madon E; Fagioli F
    Cell Immunol; 2007 Oct; 249(2):63-72. PubMed ID: 18163982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of heat-shock protein 27 expression eliminates drug resistance of osteosarcoma to zoledronic acid.
    Morii T; Ohtsuka K; Ohnishi H; Mochizuki K; Satomi K
    Anticancer Res; 2010 Sep; 30(9):3565-71. PubMed ID: 20944138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
    Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
    BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined Use of Zoledronic Acid Augments Ursolic Acid-Induced Apoptosis in Human Osteosarcoma Cells through Enhanced Oxidative Stress and Autophagy.
    Wu CC; Huang YF; Hsieh CP; Chueh PJ; Chen YL
    Molecules; 2016 Nov; 21(12):. PubMed ID: 27916903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line.
    Mackie PS; Fisher JL; Zhou H; Choong PF
    Br J Cancer; 2001 Apr; 84(7):951-8. PubMed ID: 11286476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptors 2 and 4 do not contribute to clearance of Chlamydophila pneumoniae in mice, but are necessary for the release of monokines.
    Mueller M; Postius S; Thimm JG; Gueinzius K; Muehldorfer I; Hermann C
    Immunobiology; 2004; 209(8):599-608. PubMed ID: 15638128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of levofloxacin on the viability of intracellular Chlamydia pneumoniae and modulation of proinflammatory cytokine production by human monocytes.
    Baltch AL; Smith RP; Ritz WJ; Carpenter AN; Bopp LH; Michelsen PB; Carlyn CJ; Hibbs JR
    Diagn Microbiol Infect Dis; 2004 Nov; 50(3):205-12. PubMed ID: 15541607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlamydia pneumoniae infection enhances cellular proliferation and reduces steroid responsiveness of human peripheral blood mononuclear cells via a tumor necrosis factor-alpha-dependent pathway.
    Cho YS; Kim TB; Lee TH; Moon KA; Lee J; Kim YK; Lee KY; Moon HB
    Clin Exp Allergy; 2005 Dec; 35(12):1625-31. PubMed ID: 16393329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducible expression of human β-defensin 2 by Chlamydophila pneumoniae in brain capillary endothelial cells.
    Tiszlavicz Z; Endrész V; Németh B; Megyeri K; Orosz L; Seprényi G; Mándi Y
    Innate Immun; 2011 Oct; 17(5):463-9. PubMed ID: 20647256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.